Yonghu Sun

2.0k total citations
51 papers, 361 citations indexed

About

Yonghu Sun is a scholar working on Pathology and Forensic Medicine, Immunology and Infectious Diseases. According to data from OpenAlex, Yonghu Sun has authored 51 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 14 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Yonghu Sun's work include Autoimmune Bullous Skin Diseases (18 papers), Leprosy Research and Treatment (10 papers) and Drug-Induced Adverse Reactions (9 papers). Yonghu Sun is often cited by papers focused on Autoimmune Bullous Skin Diseases (18 papers), Leprosy Research and Treatment (10 papers) and Drug-Induced Adverse Reactions (9 papers). Yonghu Sun collaborates with scholars based in China, United Kingdom and Singapore. Yonghu Sun's co-authors include Furen Zhang, Hong Liu, Lele Sun, Qing Zhao, Gongqi Yu, Jianjun Liu, Zihao Mi, Zhenzhen Wang, Chuan Wang and David A. Ostrov and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yonghu Sun

43 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghu Sun China 13 103 85 82 78 69 51 361
Lele Sun China 9 51 0.5× 62 0.7× 82 1.0× 57 0.7× 52 0.8× 40 243
Rodolfo Capizzi Italy 14 89 0.9× 41 0.5× 121 1.5× 32 0.4× 105 1.5× 40 497
Sara Mazzilli Italy 11 137 1.3× 24 0.3× 137 1.7× 22 0.3× 42 0.6× 42 413
Alan K. Silverman United States 10 111 1.1× 56 0.7× 61 0.7× 29 0.4× 61 0.9× 13 426
Melanie C. Dispenza United States 10 116 1.1× 33 0.4× 21 0.3× 17 0.2× 33 0.5× 23 419
Takahiro Kageyama Japan 12 133 1.3× 39 0.5× 34 0.4× 114 1.5× 25 0.4× 34 408
Napatra Tovanabutra Thailand 13 62 0.6× 174 2.0× 68 0.8× 14 0.2× 152 2.2× 39 445
Dilek Seçkin Türkiye 11 82 0.8× 9 0.1× 79 1.0× 27 0.3× 47 0.7× 21 293
Robert S. Lester Canada 11 23 0.2× 19 0.2× 87 1.1× 45 0.6× 51 0.7× 21 314

Countries citing papers authored by Yonghu Sun

Since Specialization
Citations

This map shows the geographic impact of Yonghu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghu Sun more than expected).

Fields of papers citing papers by Yonghu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghu Sun. The network helps show where Yonghu Sun may publish in the future.

Co-authorship network of co-authors of Yonghu Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghu Sun. A scholar is included among the top collaborators of Yonghu Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghu Sun. Yonghu Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Lele, Pengcheng Huai, Zhenzhen Wang, et al.. (2025). TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity. Signal Transduction and Targeted Therapy. 10(1). 196–196.
2.
Yang, Baoqi, Zhenzhen Wang, Tingting Liu, et al.. (2025). Efficacy, safety, and B-cell depletion capacity of 3 rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: A 52-week clinical trial. Journal of the American Academy of Dermatology. 93(3). 634–643.
3.
Fang, Xiang, et al.. (2024). Skin Biopsy Detection of Phosphorylated α‐Synuclein in Patients of Bullous Pemphigoid with or without Parkinson's Disease. Movement Disorders. 40(1). 152–156. 1 indexed citations
4.
Liu, Tingting, Zhenzhen Wang, Xiaotong Xue, et al.. (2024). Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease. Nature Communications. 15(1). 5949–5949. 15 indexed citations
6.
Wang, Tianyu & Yonghu Sun. (2024). Naevoid blaschkoid psoriasis: a curable mosaic abnormality of the skin. Clinical and Experimental Dermatology. 49(12). 1697–1699.
8.
Almutairi, Mubarak, Adam Lister, Qing Zhao, et al.. (2023). Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides. The Journal of Immunology. 210(8). 1031–1042. 3 indexed citations
9.
Li, Lichen, Lele Sun, Gongqi Yu, et al.. (2023). A Celiac Gene HLA-DQB1∗02:01 Is Associated with Linear IgA Bullous Dermatosis in the Chinese Population. Journal of Investigative Dermatology. 144(3). 713–717. 2 indexed citations
10.
Sun, Yonghu, et al.. (2022). Immunometabolism in the pathogenesis of vitiligo. Frontiers in Immunology. 13. 1055958–1055958. 25 indexed citations
11.
Zhao, Qing, Mubarak Almutairi, Arun Tailor, et al.. (2021). HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients. Journal of Investigative Dermatology. 141(10). 2412–2425.e2. 16 indexed citations
12.
Irwanto, Astrid, Ishak D. Irwan, Yonghu Sun, et al.. (2020). Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. PLoS neglected tropical diseases. 14(10). e0008746–e0008746. 20 indexed citations
13.
Li, Zhen, Hao Xu, Jialin Chen, et al.. (2020). Internet-based remote consultation facilitates the medical care of patients with chronic skin diseases during COVID-19 pandemic. Journal of Infection. 82(2). e31–e32. 5 indexed citations
14.
Zhao, Qing, et al.. (2020). Prevention and Treatment of Leprosy — China, 2009−2019. China CDC Weekly. 2(4). 53–56. 3 indexed citations
15.
Sun, Yonghu, Qing Zhao, Gongqi Yu, et al.. (2019). Rare CARD14 missense variants associated with palmoplantar pustulosis (PPP) in the Chinese Han population. European Journal of Dermatology. 29(1). 99–100. 4 indexed citations
16.
Zhang, Xuelei, Yuyan Cheng, Qun Zhang, et al.. (2018). Meta-Analysis Identifies Major Histocompatiblity Complex Loci in or Near HLA-DRB1, HLA-DQA1, HLA-C as Associated with Leprosy in Chinese Han Population. Journal of Investigative Dermatology. 139(4). 957–960. 14 indexed citations
17.
Schutte, Ryan J., et al.. (2018). Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions. Clinics in Laboratory Medicine. 38(4). 669–677. 9 indexed citations
18.
Zhao, Yaling, Terence T. Lao, Zhen Chen, et al.. (2015). Maternal gestational diabetes mellitus and overweight and obesity in offspring: a study in Chinese children. Journal of Developmental Origins of Health and Disease. 6(6). 479–484. 13 indexed citations
19.
Wang, Jing, Zhuo Chen, Minghui Yang, et al.. (2012). Relationship between maternal red cell index in early pregnancy and gestational diabetes mellitus in Kunming. Zhonghua weichan yixue zazhi. 15(12). 705–709. 1 indexed citations
20.
Sun, Yonghu, Hong Liu, Gongqi Yu, et al.. (2011). Gene expression analysis of leprosy by using a multiplex branched DNA assay. Experimental Dermatology. 20(6). 520–522. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026